GCTK - Company ID 0001506983
The table below shows GlucoTrack, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $2.13M | $3.17M | $3.15M | $1.87M | $2.06M | $3.59M |
| SG&A |
GlucoTrack, Inc. reported annual revenue of $208.00K for fiscal year 2019. That is down 100.0% from $17.00B in fiscal 2018. Over the 6 fiscal years shown, annual revenue grew from $59.77K (FY 2014) to $208.00K. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $2.07M |
| $1.02M |
| $1.46M |
| $1.63M |
| $1.06M |
| $802.00K |
| Operating income | -$4.20M | -$4.31M | -$4.80M | -$3.50M | -$3.25M | -$4.49M |
| Income tax | - | - | - | - | - | - |
| Net income | -$4.33M | -$4.17M | -$4.76M | -$6.83M | -$5.09M | -$4.49M |
| EPS (diluted) | $2.65 | $4.64 | $9.62 | $40.14 | $1.09K | $984.00 |